Skip to Main Content

Paper Details

Lipoprotein(a) and the Effect of Alirocumab on Revascularization After Acute Coronary Syndrome.
Can J Cardiol
3
2023
ACS, Acute Coronary Syndrome, Alirocumab, Lipoprotein(a), acute coronary syndrome, alirocumab, atherothrombosis, lipoprotein(a), patient, patients, statin
Author NameAffiliation
Deepak L BhattIcahn School of Medicine at Mount Sinai Health System
Robert A HarringtonStanford Center for Clinical Research, Stanford University
  • 1 - 2

Datasets

Release 1.2